TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/6/19 17:44 | 5/2/19 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Pauli Ronald | L2 | D | M.d | 0 | 0.00 | 0 | 15 | 84 | 34 | I | |||||||||||||||
5/7/18 17:03 | 5/3/18 | HZNP | Horizon Pharma Plc | DE | Health | Drug | Pharmaceutical Preparations | Pauli Ronald | L2 | D | M.d | 0 | 0.00 | 0 | 14 | 137 | 24 | I | |||||||||||||||
5/4/17 18:01 | 5/3/17 | HZNP | Horizon Pharma Plc | DE | Health | Drug | Pharmaceutical Preparations | Pauli Ronald | L2 | D | M.d | 0 | 0.00 | 33 | 14 | 999% | 14 | I | -49 | -1 | -10 | -8 | 4 | 0 | -1 | -2 | 2 | -37 | |||||
5/10/16 16:42 | 5/6/16 | HZNP | Horizon Pharma Plc | DE | Health | Drug | Pharmaceutical Preparations | Pauli Ronald | L2 | D | M.d | 0 | 0.00 | 33 | 5 | 4 | I | 16 | -45 | -12 | -5 | -4 | 6 | -1 | 4 | -5 | 1 | 25 | 41 | 2 | |||
10/6/06 12:04 | 10/5/06 | NEOL | Neopharm Inc | DE | Health | BioPrd | Biological Products, (No Diag | Pauli Ronald | IL | O | Ex. VP - | P | 11 | 5.60 | 0 | 2 | New | 2 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |